Universal Health Services, Inc. (UHS)
| Market Cap | 11.09B -15.7% |
| Revenue (ttm) | 18.11B +10.1% |
| Net Income | 1.53B +21.0% |
| EPS | 24.57 +29.7% |
| Shares Out | 58.94M |
| PE Ratio | 7.66 |
| Forward PE | 8.20 |
| Dividend | $0.80 (0.43%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 489,154 |
| Open | 183.36 |
| Previous Close | 182.87 |
| Day's Range | 182.94 - 188.86 |
| 52-Week Range | 140.08 - 246.33 |
| Beta | 1.03 |
| Analysts | Buy |
| Price Target | 196.12 (+4.25%) |
| Earnings Date | Oct 27, 2026 |
About UHS
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company’s hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capita... [Read more]
Financial Performance
In 2025, Universal Health Services's revenue was $17.36 billion, an increase of 9.71% compared to the previous year's $15.83 billion. Earnings were $1.49 billion, an increase of 30.36%.
Financial StatementsAnalyst Summary
According to 20 analysts, the average rating for UHS stock is "Buy." The 12-month stock price target is $196.12, which is an increase of 4.25% from the latest price.
News
Universal Health Services, Inc. Announces Date for Third Quarter 2026 Earnings Release and Conference Call
Universal Health Services, Inc. (NYSE: UHS) announced it will report Q3 2026 after the market close on Oct. 26, 2026 and hold its earnings call on Oct. 27.
Universal Health Services Transcript: 2026 Global Healthcare Conference
Q2 performance was strong, with revised 2026 guidance reflecting stable acute volumes and effective cost control. New facility ramp-ups and the Talkspace acquisition support growth, while exchange and Medicaid policy changes present headwinds. Outpatient behavioral expansion and virtual care are key strategic priorities.
Universal Health Services Transcript: Morgan Stanley 24th Annual Global Healthcare Conference
Q2 saw volume rebounds and strong cost control, with revised guidance reflecting some headwinds. Outpatient behavioral health and virtual care are key growth drivers, supported by the Talkspace acquisition and expansion of freestanding facilities. AI adoption is enhancing efficiency, and capital allocation remains balanced between acquisitions and share repurchases.
Universal Health Services Transcript: Wells Fargo 21st Annual Healthcare Conference
Q2 saw volume rebounds and expense control, but guidance was trimmed due to exchange headwinds and lighter surgical trends. Strategic moves include the Talkspace acquisition and physician group integration, while capacity expansions target high-demand markets. Policy and regulatory risks remain, especially around exchange and Medicaid disenrollment.
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES
KING OF PRUSSIA, Pa., Aug. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the following conferences: September 8, 2026, at 8:45am ET at the Wells Fargo...
Universal Health Services Slides: Investor presentation
Universal Health Services has posted slides in relation to its latest quarterly earnings report, which was published on August 21, 2026.
Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.
Creates nation's first full continuum of behavioral healthcare services, supporting people across every stage of their mental health journey KING OF PRUSSIA, Pa. and NEW YORK, Aug. 17, 2026 /PRNewswir...
Universal Health price target raised to $170 from $162 at BofA
BofA analyst Kevin Fischbeck raised the firm’s price target on Universal Health (UHS) to $170 from $162 and keeps an Underperform rating on the shares. July data points better than…
Universal Health price target lowered to $183 from $190 at RBC Capital
RBC Capital analyst Ben Hendrix lowered the firm’s price target on Universal Health (UHS) to $183 from $190 and keeps a Sector Perform rating on the shares. The firm is…
Universal Health price target lowered to $190 from $242 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Universal Health (UHS) to $190 from $242 and keeps a Neutral rating on the shares.
Universal Health price target lowered to $189 from $195 at Guggenheim
Guggenheim lowered the firm’s price target on Universal Health (UHS) to $189 from $195 and keeps a Buy rating on the shares. Tailwinds from items pressuring 2026 set the company…
Universal Health price target lowered to $191 from $212 at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach lowered the firm’s price target on Universal Health (UHS) to $191 from $212 and keeps an Equal Weight rating on the shares. Excluding upsides from…
Universal Health price target lowered to $290 from $310 at UBS
UBS lowered the firm’s price target on Universal Health (UHS) to $290 from $310 and keeps a Buy rating on the shares. The Q2 results were better than feared, with…
Universal Health price target lowered to $166 from $204 at Baird
Baird lowered the firm’s price target on Universal Health (UHS) to $166 from $204 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results…
Universal Health Services Earnings Call Transcript: Q2 2026
Q2 2026 featured strong acute care volume growth, stable behavioral health trends, and disciplined expense management. Updated 2026 guidance reflects higher Medicaid supplemental benefits but also increased liability reserves and operating losses at select facilities. Share repurchases accelerated, and outpatient expansion remains a strategic focus.
Universal Health Services Earnings release: Q2 2026
Universal Health Services released its Q2 2026 earnings on July 28, 2026, summarizing the period's financial results.
Universal Health Services Quarterly report: Q2 2026
Universal Health Services has published its Q2 2026 quarterly earnings report on July 28, 2026.
Universal Health price target lowered to $168 from $179 at Barclays
Barclays lowered the firm’s price target on Universal Health (UHS) to $168 from $179 and keeps an Equal Weight rating on the shares post the Q2 report. The company’s comparable…
Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty
Hospital operator Universal Health Services lowered its full-year profit forecast on Monday, citing changes in reimbursements related to certain Medicaid supplemental payment programs, sending its s...
Universal Health backs FY26 CapEx view $950M-$1.1B
16:27 EDT Universal Health (UHS) backs FY26 CapEx view $950M-$1.1B
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended June 30, 2026 and 2025: KING OF PRUSSIA, Pa., July 27, 2026 /PRNewswire/ -- Universal Health Services, Inc....
Universal Health price target lowered to $195 from $211 at Guggenheim
Guggenheim lowered the firm’s price target on Universal Health (UHS) to $195 from $211 and keeps a Buy rating on the shares. The firm updated its Q2 EBITDA estimates across…
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
KING OF PRUSSIA, Pa., July 15, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on September...
Universal Health price target lowered to $168 from $175 at BofA
BofA analyst Kevin Fischbeck lowered the firm’s price target on Universal Health (UHS) to $168 from $175 and keeps an Underperform rating on the shares. The firm cut its price…
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
KING OF PRUSSIA, Pa., July 6, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2026, after the market ...